The purpose of this study was therefore to demonstrate that doubling the dose of Seretide™ administered via a Diskus™ inhaler in subjects with varying degrees of asthma is safe and well ...

Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016 ... where the originator drug is branded as Seretide, generics have been on the market ...

However, Seretide is available both as a pMDI and in the Diskus dry powder inhaler, and is also approved for patients with chronic obstructive pulmonary disease (COPD) as well as asthma in ...

A total of 332 patients entered the study and 277 patients were randomised and treated, 137 with FP250µg twice daily via Diskus TM inhaler and 140 with budesonide 600µg twice daily via ...